Yongchao Su

Press Release 
For more information:
Rebecca Stauffer
AAPS Communications Manager
[email protected]

Yongchao Su, Ph.D., to Become Editor-in-Chief of AAPS Open

Arlington, VA—AAPS is pleased to announce Yongchao Su, Ph.D., has assumed the role of Editor-in-Chief of AAPS Open, the first open access publication dedicated to the pharmaceutical sciences. 

He will manage peer review of manuscripts under consideration by the journal, collaborate with the publisher and AAPS to select Associate Editors and the Editorial Board, and commission submissions in areas of interest and scope. In addition, he will work on journal development with the goal of furthering the journal’s impact and reach, and advancing the field of drug discovery, development, and regulation.
"I'm excited to bring my interdisciplinary expertise to the role of Editor-in-Chief of AAPS Open," said Dr. Su. "As AAPS' flagship open access publication, this peer-reviewed journal is a pivotal source of credible pharmaceutical science, offering excellent visibility and accessibility."

"AAPS Open provides the pharmaceutical communities access to new and innovative scientific thinking," said Gopi Shankar, Ph.D., M.B.A., FAAPS, the 2024 AAPS President. "Dr. Su's background, which bridges academia and industrial sciences, along with his expertise in elucidating the molecular mechanisms of drug delivery and stability for product development, will be an invaluable asset in his role as Editor-in-Chief."

Dr. Su is a Senior Principal Scientist in Pharmaceutical Sciences and Clinical Supply at Merck & Co, Inc. He also serves as an adjunct faculty member at the University of Texas at Austin, University of Connecticut, and Purdue University. He has received academic training in structural biophysics and brings nearly 10 years of industrial experience, spanning discovery, formulation, and analytical functions. As a researcher, he has published more than 120 peer-reviewed articles and has been involved with the editorial advisory boards of Pharmaceutical Research, Molecular Pharmaceutics, and the Journal of Pharmaceutical Sciences. In addition, Dr. Su served as an editor for the protein section of Amino Acids.

Currently, he serves on the Physical Analysis Expert Committee of the United States Pharmacopeia. Most recently, he served as Chair of the AAPS Career Development Committee. 

AAPS Open can be accessed at aapsopen.springeropen.com


American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and various events in person and online. www.aaps.org 

AAPS journals publish articles covering the breadth of pharmaceutical science, including complementary disciplines like chemistry, biology, and engineering. AAPS publishes four peer-reviewed journals: The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open. The latter is AAPS’ first fully open access journal. It is freely available worldwide, and authors retain copyright. All four journals are available with AAPS membership or through institutional access. www.aaps.org/journals